search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
 INNOVATION T


he goal of the Telemedicine and Advanced Technology Research Center (TATRC) of the U.S.  


 to translate research into new prod- ucts to advance the care of the Nation’s  it must encourage that next breakthrough to enhance military health, while mak- ing effective use of that it stewards.


the federal funds


To determine what it should fund, TATRC must decide whether a new tech- nology solves an important problem and who would purchase it. While all TATRC project proposals are expected to provide detail on commercial potential, the real- ity is that many researchers do not have the knowledge or resources to assess this effectively and develop a commercializa- tion strategy on their own.


To date, DOD has had no formal pro- gram to guide and assist them. For this reason, TATRC developed a compre- hensive commercialization program for the more than 1,800 research projects


84


it manages at universities, government laboratories, and high-tech start-up com- panies. It was an ambitious undertaking.


A BLANK SLATE A funded research project is only half the journey in providing a solution for Sol- diers or bringing the lessons learned from        set out to develop a holistic Technology Transfer/Commercialization Program (T2/C) that would help achieve three pri- mary objectives:


 - tial of new discoveries and technologies.


     with investors.


  impact of the precious research dollars that the center manages for the military.


It faced a blank slate in all three areas.


In 2009, TATRC started a formal pro- gram leveraging federal investment with private-sector capital to commercialize federal medical research and develop- ment (R&D) technologies. It examined





TATRC’s Technology Transfer/Commercialization Program could be a model for speeding viable 


by Ronald Marchessault Jr., Dr. Charles M. Peterson, and COL Karl E. Friedl


similar efforts at the National Insti-      exhaustively to reach out to groups with the right ideas and right capabilities to support these objectives. TATRC chose -  or risk in sharing proprietary informa-      measures of outcome


that will allow


tracking and continuous improvement of the program.


The hope is that TATRC’s pilot program will become a blueprint for others


DOD. This strategy of “convergence management” parallels the innovative approach


to fostering “convergence


science” as developed by TATRC and described in “Promoting Innovation   Technology-Inspired


Problem Solving”


(    , Volume 12, Issue 3).


PROJECT ASSESSMENT T2/C sought


out several strategic


partners and resources to provide the business expertise that must marry with


in


Army AL&T Magazine


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203